PDT Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-92,800
Closed -$5.86M 1221
2015
Q3
$5.86M Buy
92,800
+54,012
+139% +$3.86M 0.13% 195
2015
Q2
$2.83M Buy
38,788
+18,588
+92% +$1.34M 0.07% 317
2015
Q1
$1.32M Buy
20,200
+5,100
+34% +$339K 0.03% 655
2014
Q4
$982K Buy
15,100
+1,200
+9% +$77.3K 0.09% 290
2014
Q3
$836K Buy
13,900
+4,900
+54% +$320K 0.02% 756
2014
Q2
$623K Sell
9,000
-45,027
-83% -$2.92M 0.02% 875
2014
Q1
$3.53M Buy
54,027
+44,227
+451% +$2.88M 0.09% 294
2013
Q4
$607K Buy
9,800
+1,400
+17% +$81.1K 0.07% 341
2013
Q3
$451K Sell
8,400
-1,700
-17% -$87.6K 0.01% 1083
2013
Q2
$461K Buy
+10,100
New +$438K 0.01% 1094

Other funds holding STJ

PDT Partners's STJ Position: Q4 2015 in Review

PDT Partners sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 92,800 shares — an estimated $5.86M sold.

PDT Partners first reported a position in STJ in Q2 2013 and held it in 10 quarters. The position peaked at $5.86M in Q3 2015. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • PDT Partners reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 92,800 St Jude Medical shares in Q4 2015, an estimated $5.86M.
  • PDT Partners first reported a position in St Jude Medical in Q2 2013 and held it in 10 quarters.
  • PDT Partners's St Jude Medical position peaked at $5.86M in Q3 2015.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.